Amphastar Pharmaceuticals (AMPH) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Amphastar Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$593.24M

Latest Revenue (Q)

$188.82M

Main Segment (Y)

Active Pharmaceutical Ingredient Segment

Main Geography (Y)

Amphastar Pharmaceuticals Revenue by Period

Amphastar Pharmaceuticals Revenue by Year

Date	Revenue	Change
2023-12-31	$593.24M	18.89%
2022-12-31	$498.99M	13.98%
2021-12-31	$437.77M	25.13%
2020-12-31	$349.85M	8.53%
2019-12-31	$322.36M	9.40%
2018-12-31	$294.67M	22.69%
2017-12-31	$240.18M	-5.87%
2016-12-31	$255.16M	1.45%
2015-12-31	$251.52M	19.51%
2014-12-31	$210.46M	-8.37%
2013-12-31	$229.68M	12.41%
2012-12-31	$204.32M	72.63%
2011-12-31	$118.36M	-

Amphastar Pharmaceuticals generated $593.24M in revenue during NA 2023, up 18.89% compared to the previous quarter, and up 201.33% compared to the same period a year ago.

Amphastar Pharmaceuticals Revenue by Quarter

Date	Revenue	Change
2024-09-30	$188.82M	3.52%
2024-06-30	$182.39M	6.14%
2024-03-31	$171.84M	-3.52%
2023-12-31	$178.10M	-1.36%
2023-09-30	$180.56M	23.91%
2023-06-30	$145.71M	4.06%
2023-03-31	$140.02M	3.70%
2022-12-31	$135.02M	12.40%
2022-09-30	$120.13M	-2.70%
2022-06-30	$123.47M	2.57%
2022-03-31	$120.37M	-0.43%
2021-12-31	$120.89M	7.74%
2021-09-30	$112.20M	10.36%
2021-06-30	$101.66M	-1.32%
2021-03-31	$103.02M	7.40%
2020-12-31	$95.92M	14.97%
2020-09-30	$83.43M	-2.77%
2020-06-30	$85.81M	1.32%
2020-03-31	$84.69M	1.57%
2019-12-31	$83.38M	4.05%
2019-09-30	$80.14M	1.38%
2019-06-30	$79.05M	-0.93%
2019-03-31	$79.79M	-11.04%
2018-12-31	$89.69M	18.73%
2018-09-30	$75.54M	6.34%
2018-06-30	$71.04M	21.66%
2018-03-31	$58.39M	-3.33%
2017-12-31	$60.40M	4.29%
2017-09-30	$57.92M	-11.15%
2017-06-30	$65.19M	15.03%
2017-03-31	$56.67M	-10.82%
2016-12-31	$63.54M	-1.06%
2016-09-30	$64.22M	-5.60%
2016-06-30	$68.03M	14.60%
2016-03-31	$59.37M	-22.81%
2015-12-31	$76.91M	20.42%
2015-09-30	$63.87M	18.60%
2015-06-30	$53.85M	-5.33%
2015-03-31	$56.89M	1.81%
2014-12-31	$55.88M	-6.42%
2014-09-30	$59.71M	21.85%
2014-06-30	$49.00M	6.83%
2014-03-31	$45.87M	-16.41%
2013-12-31	$54.88M	-7.49%
2013-09-30	$59.32M	-5.13%
2013-06-30	$62.52M	18.05%
2013-03-31	$52.96M	-

Amphastar Pharmaceuticals generated $188.82M in revenue during Q3 2024, up 3.52% compared to the previous quarter, and up 129.58% compared to the same period a year ago.

Amphastar Pharmaceuticals Revenue Breakdown

Amphastar Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 20	Dec 19	Dec 18
Active Pharmaceutical Ingredient Segment	$18.48M	$20.36M	$23.61M

Amphastar Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 20: Active Pharmaceutical Ingredient Segment (100.00%).

Quarterly Revenue by Product

Product/Service	Sep 24	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18	Jun 18	Mar 18
Product and Service, Other	$2.40M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product	$188.82M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Active Pharmaceutical Ingredient Segment	-	$6.94M	$5.14M	$8.12M	$2.10M	$4.87M	$3.39M	$5.39M	$4.41M	$5.31M	$5.25M	$3.78M	$7.80M	$5.28M	-
Finished Pharmaceutical Products Segment	-	-	-	-	-	-	-	-	-	-	-	$82.93M	-	-	-

Amphastar Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (98.75%), and Product and Service, Other (1.25%).

Amphastar Pharmaceuticals Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 20	Dec 19	Dec 18
Active Pharmaceutical Ingredient Segment	$18.48M	-	-
C	$3.16M	$1.48M	-
U	$333.09M	$304.90M	$279.12M

Amphastar Pharmaceuticals's latest annual revenue breakdown by geography, as of Dec 20: U (93.90%), Active Pharmaceutical Ingredient Segment (5.21%), and C (0.89%).

Quarterly Revenue by Country

Country	Sep 24	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Sep 18	Jun 18	Mar 18
CHINA	$178.00K	-	-	-	-	-	-	-	-	-	-	-	-	-
FRANCE	$4.52M	-	-	-	-	-	-	-	-	-	-	-	-	-
UNITED STATES	$186.51M	-	-	-	-	-	-	-	-	-	-	-	-	-
C	-	$1.13M	$1.12M	$679.00K	$1.96M	$295.00K	$228.00K	$438.00K	$59.00K	$984.00K	-	-	-	-
U	-	$95.19M	$99.17M	$90.72M	$79.41M	$81.90M	$81.06M	$77.59M	$76.07M	$74.78M	$76.46M	$72.48M	$68.56M	$53.10M
Active Pharmaceutical Ingredient Segment	-	$6.94M	-	-	-	-	-	-	-	-	-	-	-	-

Amphastar Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (97.54%), FRANCE (2.36%), and CHINA (0.09%).

Amphastar Pharmaceuticals Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
NBIX	Neurocrine Biosciences	$1.89B	$622.10M
ALKS	Alkermes	$1.66B	$378.14M
PBH	Prestige Consumer Healthcare	$1.13B	$283.55M
PAHC	Phibro Animal Health	$977.89M	$273.16M
EVO	Evotec SE	$781.43M	$208.73M
PCRX	Pacira BioSciences	$674.98M	$168.57M
SUPN	Supernus Pharmaceuticals	$607.52M	$175.69M
AMPH	Amphastar Pharmaceuticals	$593.24M	$188.82M
COLL	Collegium Pharmaceutical	$566.77M	$159.30M
ANIP	ANI Pharmaceuticals	$486.82M	$148.33M
IRWD	Ironwood Pharmaceuticals	$442.74M	$91.59M
EOLS	Evolus	$199.72M	$60.16M

AMPH Revenue FAQ

What is Amphastar Pharmaceuticals’s yearly revenue?

Amphastar Pharmaceuticals's yearly revenue for 2023 was $593.24M, representing an increase of 18.89% compared to 2022. The company's yearly revenue for 2022 was $498.99M, representing an increase of 13.98% compared to 2021. AMPH's yearly revenue for 2021 was $437.77M, representing an increase of 25.13% compared to 2020.

What is Amphastar Pharmaceuticals’s quarterly revenue?

Amphastar Pharmaceuticals's quarterly revenue for Q3 2024 was $188.82M, a 3.52% increase from the previous quarter (Q2 2024), and a 4.58% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $182.39M, a 6.14% increase from the previous quarter (Q1 2024), and a 25.17% increase year-over-year (Q2 2023). AMPH's quarterly revenue for Q1 2024 was $171.84M, a -3.52% decrease from the previous quarter (Q4 2023), and a 22.72% increase year-over-year (Q1 2023).

What is Amphastar Pharmaceuticals’s revenue growth rate?

Amphastar Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 35.51%, and for the last 5 years (2019-2023) was 84.03%.

What are Amphastar Pharmaceuticals’s revenue streams?

Amphastar Pharmaceuticals's revenue streams in c 20 are Active Pharmaceutical Ingredient Segment

What is Amphastar Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 20, the largest source of revenue of Amphastar Pharmaceuticals was Active Pharmaceutical Ingredient Segment. This segment made a revenue of $18.48M, representing 100.00% of the company's total revenue.